Protein prenylation: Enzymes, therapeutics, and biotechnology applications

ACS Chemical Biology

Volumn 10, Issue 1, 2015, Pages 51-62

  Palsuledesai, Charuta C ^a   Distefano, Mark D ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLALLYLTRANSFERASE; ISOPRENOID; PROTEOME; TRANSFERASE INHIBITOR; ENZYME INHIBITOR; RAS PROTEIN; TERPENE;

AGING; BACTERIAL INFECTION; BIOCHEMISTRY; BIOTECHNOLOGY; ENZYME INHIBITION; ENZYME SPECIFICITY; ENZYMOLOGY; EUKARYOTIC CELL; HUMAN; INFECTION; MALIGNANT NEOPLASTIC DISEASE; PARASITOSIS; PRIORITY JOURNAL; PROGERIA; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PRENYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; VIRUS INFECTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; PROCEDURES;

BACTERIA (MICROORGANISMS); EUKARYOTA;

ANIMALS; BIOTECHNOLOGY; DIMETHYLALLYLTRANSTRANSFERASE; ENZYME INHIBITORS; HUMANS; PROTEIN PRENYLATION; RAS PROTEINS; SUBSTRATE SPECIFICITY; TERPENES;

EID: 84921325836     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb500791f     Document Type: Review

References (128)

1. Kamiya, Y., Sakurai, A., Tamura, S., Takahashi, N., Abe, K., Tsuchiya, E., Fukui, S., Kitada, C., and Fujino, M. (1978) Structure of rhodotorucine-A, a novel lipopeptide, inducing mating tube formation in rhodoporidium-toruloids Biochem. Biophys. Res. Commun. 83, 1077-1083
2. Wolda, S. L. and Glomset, J. A. (1988) Evidence for modification of Lamin B by a product of mevalonic acid J. Biol. Chem. 263, 5997-6000
3. Farnsworth, C. C., Wolda, S. L., Gelb, M. H., and Glomset, J. A. (1989) Human Lamin-B contains a farnesylated cysteine residue J. Biol. Chem. 264, 20422-20429
4. Zhang, F. L. and Casey, P. J. (1996) Protein prenylation: Molecular mechanisms and functional consequences Annu. Rev. Biochem. 65, 241-269
5. Ghomashchi, F., Zhang, X. H., Liu, L., and Gelb, M. H. (1995) Binding of prenylated and polybasic peptides to membranes-affinities and intervesicle exchange Biochemistry 34, 11910-11918
6. Resh, M. D. (2006) Trafficking and signaling by fatty-acylated and prenylated proteins Nat. Chem. Biol. 2, 584-590
7. Seabra, M. C. (1998) Membrane association and targeting of prenylated Ras-like GTPases Cell. Signalling 10, 167-172
8. Placzek, A. T., Krzysiak, A. J., and Gibbs, R. A. (2011) Chemical probes of protein prenylation Enzymes 30, 91-127
9. Jackson, J. H., Cochrane, C. G., Bourne, J. R., Solski, P. A., Buss, J. E., and Der, C. J. (1990) Farnesol modification of Kristen-ras exon 4B is essential for transformation Proc. Natl. Acad. Sci. U. S. A. 87, 3042-3046
10. Berndt, N., Hamilton, A. D., and Sebti, S. M. (2011) Targeting protein prenylation for cancer therapy Nat. Rev. Cancer 11, 775-791
11. Zhang, H., Seabra, M. C., and Deisenhofer, J. (2000) Crystal structure of Rab geranylgeranyltransferase at 2.0 angstrom resolution Structure 8, 241-251
12. Taylor, J. S., Reid, T. S., Terry, K. L., Casey, P. J., and Beese, L. S. (2003) Structure of mammalian protein geranylgeranyltransferase type-I EMBO J. 22, 5963-5974
13. Pompliano, D. L., Schaber, M. D., Mosser, S. D., Omer, C. A., Shafer, J. A., and Gibbs, J. B. (1993) Isoprenoid diphosphate utilization by recombinant human farnesyl-protein transferase-interactive binding between substrates and a preferred kinetic pathway Biochemistry 32, 8341-8347
14. Dolence, J. M., Cassidy, P. B., Mathis, J. R., and Poulter, C. D. (1995) Yeast protein farnesyltransferase: Steady-state kinetic studies of substrate binding Biochemistry 34, 16687-16694
15. Long, S. B., Casey, P. J., and Beese, L. S. (2002) Reaction path of protein farnesyltransferase at atomic resolution Nature 419, 645-650
16. Pickett, J. S., Bowers, K. E., Hartman, H. L., Fu, H. W., Embry, A. C., Casey, P. J., and Fierke, C. A. (2003) Kinetic studies of protein farnesyltransferase mutants establish active substrate conformation Biochemistry 42, 9741-9748
17. Yang, Y., Wang, B., Ucisik, M. N., Cui, G., Fierke, C. A., and Merz, K. M., Jr. (2012) Insights into the mechanistic dichotomy of the protein farnesyltransferase peptide substrates CVIM and CVLS J. Am. Chem. Soc. 134, 820-823
18. Mu, Y. Q., Omer, C. A., and Gibbs, R. A. (1996) On the stereochemical course of human protein-farnesyl transferase J. Am. Chem. Soc. 118, 117-123
19. Edelstein, R. L., Weller, V. A., Distefano, M. D., and Tung, J. S. (1998) Stereochemical Analysis of the Reaction Catalyzed by Yeast Protein Farnesyltransferase J. Org. Chem. 63, 5298-5299
20. Dolence, J. M. and Poulter, C. D. (1995) A Mechanism for Posttranslational Modifications of Proteins by Yeast Protein Farnesyltransferase Proc. Natl. Acad. Sci. U.S.A. 92, 5008-5011
21. Mu, Y. Q., Gibbs, R. A., Eubanks, L. M., and Poulter, C. D. (1996) Cuprate-mediated synthesis and biological evaluation of cyclopropyl- and tert-butylfarnesyl diphosphate analogs J. Org. Chem. 61, 8010-8015
22. Weller, V. A. and Distefano, M. D. (1998) Measurement of the alpha-secondary kinetic isotope effect for a prenyltransferase by MALDI mass spectrometry J. Am. Chem. Soc. 120, 7975-7976
23. Pais, J. E., Bowers, K. E., and Fierke, C. A. (2006) Measurement of the alpha-secondary kinetic isotope effect for the reaction catalyzed by mammalian protein farnesyltransferase J. Am. Chem. Soc. 128, 15086-15087
24. Lenevich, S., Xu, J., Hosokawa, A., Cramer, C. J., and Distefano, M. D. (2007) Transition state analysis of model and enzymatic prenylation reactions J. Am. Chem. Soc. 129, 5796-5797
25. Ho, M.-H., Vivo, M. D., Peraro, M. D., and Klein, M. L. (2009) Unraveling the Catalytic Pathway of Metalloenzyme Farnesyltransferase through QM/MM Computation J. Chem. Theory Comput. 5, 1657-1666
26. 2+-farnesyltransferase indicates metal coordination of the substrate thiolate J. Biol. Chem. 272, 20-23
27. Rozema, D. B. and Poulter, C. D. (1999) Yeast protein farnesyltransferase. pK(a)s of peptide substrates bound as zinc thiolates Biochemistry 38, 13138-13146
28. Tobin, D. A., Pickett, J. S., Hartman, H. L., Fierke, C. A., and Penner-Hahn, J. E. (2003) Structural Characterization of the Zinc Site in Protein Farnesyltransferase J. Am. Chem. Soc. 125, 9962-9969
29. Yokoyama, K., McGeady, P., and Gelb, M. H. (1995) Mammalian protein geranylgeranyltransferase-I: Substrate specificity, kinetic mechanism, metal requirements, and affinity labeling Biochemistry 34, 1344-1354
30. Clausen, V. A., Edelstein, R. L., and Distefano, M. D. (2001) Stereochemical analysis of the reaction catalyzed by human protein geranylgeranyl transferase Biochemistry 40, 3920-3930
31. Hartman, H. L., Bowers, K. E., and Fierke, C. A. (2004) Lysine b311 of Protein Geranylgeranyltransferase Type I Partially Replaces Magnesium J. Biol. Chem. 279, 30546-30553
32. Terry, K. L., Casey, P. J., and Beese, L. S. (2006) Conversion of protein farnesyltransferase to a geranylgeranyltransferase Biochemistry 45, 9746-9755
33. Desnoyers, L., Anant, J. S., and Seabra, M. C. (1996) Geranylgeranylation of Rab proteins Biochem. Soc. Trans. 24, 699-703
34. Witter, D. J. and Poulter, C. D. (1996) Yeast geranylgeranyltransferase type-II: Steady state kinetic studies of the recombinant enzyme Biochemistry 35, 10454-10463
35. Zhang, H., Seabra, M. C., and Deisenhofer, J. (2000) Crystal Structure of Rab geranylgeranyltransferase at 2.0 A resolution Structure 8, 241-251
36. Guo, Z., Wu, Y.-W., Das, D., Delon, C., Cramer, J., Yu, S., Thuns, S., Lupilova, N., Waldmann, H., Brunsveld, L., Goody, R. S., Alexandrov, K., and Blankenfeldt, W. (2008) Structures of RabGGTase-substrate/product complexes provide insights into the evolution of protein prenylation EMBO J. 27, 2444-2456
37. Schuld, N. J., Vervacke, J. S., Lorimer, E. L., Simon, N. C., Hauser, A. D., Barbieri, J. T., Distefano, M. D., and Williams, C. L. (2014) The chaperone protein SmgGDS interacts with small GTPases entering the prenylation pathway by recognizing the last amino acid in the CAAX motif J. Biol. Chem. 289, 6862-6876
38. Ochocki, J. D. and Distefano, M. D. (2013) Prenyltransferase inhibitors: treating human ailments from cancer to parasitic infections MedChemComm 4, 476-492
39. London, N., Lamphear, C. L., Hougland, J. L., Fierke, C. A., and Schueler-Furman, O. (2011) Identification of a novel class of farnesylation targets by structure-based modeling of binding specificity Plos Comput. Biol. 7 e1002170
40. Maurer-Stroh, S., Koranda, M., Benetka, W., Schneider, G., Sirota, F. L., and Eisenhaber, F. (2007) Towards complete sets of farnesylated and geranylgeranylated proteins Plos Comput. Biol. 3 e66
41. Maurer-Stroh, S. and Eisenhaber, F. (2005) Refinement and prediction of protein prenylation motifs Genome Biol. 6, R55
42. Hougland, J. L., Hicks, K. A., Hartman, H. L., Kelly, R. A., Watt, T. J., and Fierke, C. A. (2010) Identification of novel peptide substrates for protein farnesyltransferase reveals two substrate classes with distinct sequence selectivities J. Mol. Biol. 395, 176-190
43. Reiss, Y., Stradley, S. J., Gierasch, L. M., Brown, M. S., and Goldstein, J. L. (1991) Sequence requirement for peptide recognition by rat-brain P21Ras protein farnesyltransferase Proc. Natl. Acad. Sci. U. S. A. 88, 732-736
44. Hightower, K. E., Huang, C. C., Casey, P. J., and Fierke, C. A. (1998) H-Ras peptide and protein substrates bind protein farnesyltransferase as an ionized thiolate Biochemistry 37, 15555-15562
45. Pompliano, D. L., Gomez, R. P., and Anthony, N. J. (1992) Intramolecular fluorescence enhancement- A continuous assay of Ras farnesyl-protein transferase J. Am. Chem. Soc. 114, 7945-7946
46. Stirtan, W. G. and Poulter, C. D. (1995) Yeast protein geranylgeranyltransferase type-I-Overproduction, purification, and characterization Arch. Biochem. Biophys. 321, 182-190
47. Boutin, J. A., Marande, W., Petit, L., Loynel, A., Desmet, C., Canet, E., and Fauchére, J. L. (1999) Investigation of S-farnesyl transferase substrate specificity with combinatorial tetrapeptide libraries Cell. Signalling. 11, 59-69
48. Krzysiak, A. J., Scott, S. A., Hicks, K. A., Fierke, C. A., and Gibbs, R. A. (2007) Evaluation of protein farnesyltransferase substrate specificity using synthetic peptide libraries Bioorg. Med. Chem. Lett. 17, 5548-5551
49. Krzysiak, A. J., Aditya, A. V., Hougland, J. L., Fierke, C. A., and Gibbs, R. A. (2010) Synthesis and screening of a CaaL peptide library versus FTase reveals a surprising number of substrates Bioorg. Med. Chem. Lett. 20, 767-770
50. Hougland, J. L., Lamphear, C. L., Scott, S. A., Gibbs, R. A., and Fierke, C. A. (2009) Context-dependent substrate recognition by protein farnesyltransferase Biochemistry 48, 1691-1701
51. Lamphear, C. L., Zverina, E. A., Hougland, J. L., and Fierke, C. A. (2011) Global identification of protein prenyltransferase substrates: defining the prenylated proteome Enzymes 29, 207-234
52. Wang, Y.-C. and Distefano, M. D. (2012) Solid-phase synthesis of C-terminal peptide libraries for studying the specificity of enzymatic protein prenylation Chem. Commun. 48, 8228-8230
53. Wang, Y.-C., Dozier, J. K., Beese, L. S., and Distefano, M. D. (2014) Rapid analysis of protein farnesyltransferase substrate specificity using peptide libraries and isoprenoid diphosphate analogues ACS Chem. Biol. 9, 1726-1735
54. Omer, C. A., Kral, A. M., Diehl, R. E., Prendergast, G. C., Powers, S., Allen, C. M., Gibbs, J. B., and Kohl, N. E. (1993) Characterization of recombinant human farnesyl-protein transferase: Cloning, expression, farnesyl diphosphate binding, and functional homology with yeast prenyl-protein transferases Biochemistry 32, 5167-5176
55. Bukhtiyarov, Y. E., Omer, C. A., and Allen, C. M. (1995) Photoreactive analogs of prenyl diphosphates as inhibitors and probes of human protein farnesyltransferase and geranylgeranyltransferase type-I J. Biol. Chem. 270, 19035-19040
56. Edelstein, R. L. and Distefano, M. D. (1997) Photoaffinity labeling of yeast farnesyl protein transferase and enzymatic synthesis of a Ras protein incorporating a photoactive isoprenoid Biochem. Biophys. Res. Commun. 235, 377-382
57. Gaon, I., Turek, T. C., and Distefano, M. D. (1996) Farnesyl and geranylgeranyl pyrophosphate analogs incorporating benzoylbenzyl ethers: synthesis and inhibition of yeast protein farnesyltransferase Tetrahedron Lett. 37, 8833-8836
58. Gaon, I., Turek, T. C., Weller, V. A., Edelstein, R. L., Singh, S. K., and Distefano, M. D. (1996) Photoactive Analogs of Farnesyl Pyrophosphate Containing Benzoylbenzoate Esters: Synthesis and Application to Photoaffinity Labeling of Yeast Farnesyltransferase J. Org. Chem. 61, 7738-7745
59. Turek, T. C., Gaon, I., and Distefano, M. D. (1996) Analogs of farnesyl pyrophosphate incorporating internal benzoylbenzoate esters: Synthesis, inhibition kinetics and photoinactivation of yeast protein farnesyltransferase Tetrahedron Lett. 37, 4845-4848
60. Turek, T. C., Gaon, I., Distefano, M. D., and Strickland, C. L. (2001) Synthesis of Farnesyl Diphosphate Analogues Containing Ether-Linked Photoactive Benzophenones and Their Application in Studies of Protein Prenyltransferases J. Org. Chem. 66, 3253-3264
61. Turek, T. C., Gaon, I., Gamache, D., and Distefano, M. D. (1997) Synthesis and evaluation of benzophenone-based photoaffinity labeling analogs of prenyl pyrophosphates containing stable amide linkages Bioorg. Med. Chem. Lett. 7, 2125-2130
62. Quellhorst, G. J., Allen, C. M., and Wessling-Resnick, M. (2001) Modification of Rab5 with a photoactivatable analog of geranylgeranyl diphosphate J. Biol. Chem. 276, 40727-40733
63. Turek-Etienne, T. C., Strickland, C. L., and Distefano, M. D. (2003) Biochemical and structural studies with prenyl diphosphate analogues provide insights into isoprenoid recognition by protein farnesyl transferase Biochemistry 42, 3716-3724
64. Hovlid, M. L., Edelstein, R. L., Henry, O., Ochocki, J., DeGraw, A., Lenevich, S., Talbot, T., Young, V. G., Hruza, A. W., Lopez-Gallego, F., Labello, N. P., Strickland, C. L., Schmidt-Dannert, C., and Distefano, M. D. (2010) Synthesis, properties, and applications of diazotrifluropropanoyl-containing photoactive analogs of farnesyl diphosphate containing modified linkages for enhanced stability Chem. Biol. Drug Des. 75, 51-67
65. Vervacke, J. S., Funk, A. L., Wang, Y.-C., Strom, M., Hrycyna, C. A., and Distefano, M. D. (2014) Diazirine-containing photoactivatable isoprenoid: synthesis and application in studies with isoprenylcysteine carboxyl methyltransferase J. Org. Chem. 79, 1971-1978
66. DeGraw, A. J., Zhao, Z., Hsieh, J., Jefferies, M., Distefano, M. D., Strickland, C. L., Shintani, D., Nural, H., McMahan, C., and Xie, W. (2007) A photoactive isoprenoid diphosphate analogue containing a stable phosphonate linkage: synthesis and structural biochemical studies with prenyltransferases J. Org. Chem. 72, 4587-4595
67. Strickland, C. L., Windsor, W. T., Syto, R., Wang, L., Bond, R., Wu, Z., Schwartz, J., Le, H. V., Beese, L. S., and Weber, P. C. (1998) Crystal structure of farnesyl protein transferase complexed with a CaaX peptide and farnesyl diphosphate analogue Biochemistry 37, 16601-16611
68. Zahn, T. J., Whitney, J., Weinbaum, C., and Gibbs, R. A. (2001) Synthesis and evaluation of GGPP geometric isomers: Divergent substrate specificities of FTase and GGTase I Bioorg. Med. Chem. Lett. 11, 1605-1608
69. Subramanian, T., Pais, J. E., Liu, S., Troutman, J. M., Suzuki, Y., Subramanian, K. L., Fierke, C. A., Andres, D. A., and Spielmann, H. P. (2012) Farnesyl Diphosphate Analogues with Aryl Moieties Are Efficient Alternate Substrates for Protein Farnesyltransferase Biochemistry 51, 8307-8319
70. Roberts, M. J., Troutman, J. M., Chehade, K. A. H., Cha, H. C., Kao, J. P. Y., Huang, X., Zhan, C.-G., Peterson, Y. K., Subramanian, T., Kamalakkannan, S., Andres, D. A., and Spielmann, H. P. (2006) Hydrophilic anilinogeranyl diphosphate prenyl analogues are Ras function inhibitors Biochemistry 45, 15862-15872
71. Troutman, J. M., Subramanian, T., Andres, D. A., and Spielmann, H. P. (2007) Selective modification of CaaX peptides with ortho-substituted anilinogeranyl lipids by protein farnesyl transferase: Competitive substrates and potent inhibitors from a library of farnesyl diphosphate analogues Biochemistry 46, 11310-11321
72. Gibbs, B. S., Zahn, T. J., Mu, Y. Q., Sebolt-Leopold, J. S., and Gibbs, R. A. (1999) Novel farnesol and geranylgeraniol analogues: A potential new class of anticancer agents directed against protein prenylation J. Med. Chem. 42, 3800-3808
73. Krzysiak, A. J., Rawat, D. S., Scott, S. A., Pais, J. E., Handley, M., Harrison, M. L., Fierke, C. A., and Gibbs, R. A. (2007) Combinatorial Modulation of Protein Prenylation ACS Chem. Biol. 2, 385-389
74. Das, D., Tnimov, Z., Nguyen, U. n. T. T., Thimmaiah, G., Lo, H., Abankwa, D., Wu, Y., Goody, R. S., Waldmann, H., and Alexandrov, K. (2012) Flexible and general synthesis of functionalized phosphoisoprenoids for the study of prenylation in vivo and in vitro ChemBioChem 13, 674-683
75. Dozier, J. K., Khatwani, S. L., Wollack, J. W., Wang, Y.-C., Schmidt-Dannert, C., and Distefano, M. D. (2014) Engineering protein farnesyltransferase for enzymatic protein labeling applications Bioconjugate Chem. 25, 1203-1212
76. Kim, M. K., Kleckley, T. S., Wiemer, A. J., Holstein, S. A., Hohl, R. J., and Wiemer, D. F. (2004) Synthesis and activity of fluorescent isoprenoid pyrophosphate analogues J. Org. Chem. 69, 8186-8193
77. Placzek, A. T., Krzysiak, A. J., and Gibbs, R. A. (2011) Chemical probes of protein prenylation, in Protein Prenylation, Part B (Hrycyna, C. A., Bergo, M. O., and Tamanoi, F., Eds.), Enzymes, Vol. 30, pp 91-127, Elsevier, Amsterdam.
78. Patel, D. V., Schmidt, R. J., Biller, S. A., Gordon, E. M., Robinson, S. S., and Manne, V. (1995) Farnesyl Diphosphate-Based Inhibitors of Ras Farnesyl Protein Transferase J. Med. Chem. 38, 2906-2921
79. Kho, Y., Kim, S. C., Jiang, C., Barma, D., Kwon, S. W., Cheng, J., Jaunbergs, J., Weinbaum, C., Tamanoi, F., Falck, J., and Zhao, Y. (2004) A tagging-via-substrate technology for detection and proteomics of farnesylated proteins Proc. Natl. Acad. Sci. U. S. A. 101, 12479-12484
80. Chan, L. N., Hart, C., Guo, L., Nyberg, T., Davies, B. S. J., Fong, L. G., Young, S. G., Agnew, B. J., and Tamanoi, F. (2009) A novel approach to tag and identify geranylgeranylated proteins Electrophoresis 30, 3598-3606
81. Berry, A. F. H., Heal, W. P., Tarafder, A. K., Tolmachova, T., Baron, R. A., Seabra, M. C., and Tate, E. W. (2010) Rapid multilabel detection of geranylgeranylated proteins by using bioorthogonal ligation chemistry ChemBioChem 11, 771-773
82. DeGraw, A. J., Palsuledesai, C., Ochocki, J. D., Dozier, J. K., Lenevich, S., Rashidian, M., and Distefano, M. D. (2010) Evaluation of Alkyne-Modified Isoprenoids as Chemical Reporters of Protein Prenylation Chem. Biol. Drug Des. 76, 460-471
83. Charron, G., Tsou, L. K., Maguire, W., Yount, J. S., and Hang, H. C. (2011) Alkynyl-farnesol reporters for detection of protein S-prenylation in cells Mol. BioSyst. 7, 67-73
84. Duckworth, B. P., Zhang, Z., Hosokawa, A., and Distefano, M. D. (2007) Selective labeling of proteins by using protein farnesyltransferase ChemBioChem 8, 98-105
85. Hosokawa, A., Wollack, J. W., Zhang, Z. Y., Chen, L., Barany, G., and Distefano, M. D. (2007) Evaluation of an alkyne-containing analogue of farnesyl diphosphate as a dual substrate for protein-prenyltransferases Int. J. Pept. Res. Ther. 13, 345-354
86. Palsuledesai, C. C., Ochocki, J. D., Markowski, T. W., and Distefano, M. D. (2014) A combination of metabolic labeling and 2D-DIGE analysis in response to a farnesyltransferase inhibitor facilitates the discovery of new prenylated proteins Mol. BioSyst. 10, 1094-1103
87. Reinicke, A. T., Hutchinson, J. L., Magee, A. I., Mastroeni, P., Trowsdale, J., and Kelly, A. P. (2005) A Salmonella typhimurium effector protein SifA is modified by host cell prenylation and S-acylation machinery J. Biol. Chem. 280, 14620-14627
88. Price, C. T. D., Al-Quadan, T., Santic, M., Jones, S. C., and Abu Kwaik, Y. (2010) Exploitation of conserved eukaryotic host cell farnesylation machinery by an F-box effector of Legionella pneumophila J. Exp. Med. 207, 1712-1725
89. Ivanov, S. S., Charron, G., Hang, H. C., and Roy, C. R. (2010) Lipidation by the host prenyltransferase machinery facilitates membrane localization of legionella pneumophila effector proteins J. Biol. Chem. 285, 34686-34698
90. Marakasova, E. S., Akhmatova, N. K., Amaya, M., Eisenhaber, B., Eisenhaber, F., van Hoek, M. L., and Baranova, A. V. (2013) Prenylation: From bacteria to eukaryotes Mol. Biol. 47, 622-633
91. Charron, G., Li, M. M. H., MacDonald, M. R., and Hang, H. C. (2013) Prenylome profiling reveals S-farnesylation is crucial for membrane targeting and antiviral activity of ZAP long-isoform Proc. Natl. Acad. Sci. U. S. A. 110, 11085-11090
92. Nguyen, U. T. T., Guo, Z., Delon, C., Wu, Y., Deraeve, C., Fraenzel, B., Bon, R. S., Blankenfeldt, W., Goody, R. S., Waldmann, H., Wolters, D., and Alexandrov, K. (2009) Analysis of the eukaryotic prenylome by isoprenoid affinity tagging Nat. Chem. Biol. 5, 227-235
93. Onono, F. O., Morgan, M. A., Spielmann, H. P., Andres, D. A., Subramanian, T., Ganser, A., and Reuter, C. W. M. (2010) A tagging-via-substrate approach to detect the farnesylated proteome using two-dimensional electrophoresis coupled with Western blotting Mol. Cell. Proteomics 9, 742-751
94. Porcu, G., Wilson, C., Di Giandomenico, D., and Ragnini-Wilson, A. (2010) A yeast-based genomic strategy highlights the cell protein networks altered by FTase inhibitor peptidomimetics Mol. Cancer 9, 197
95. Schafer, W. R., Kim, R., Sterne, R., Thorner, J., Kim, S. H., and Rine, J. (1989) Genetic and pharmacological suppression of oncogenic mutations in Ras genes of yeast and humans Science 245, 379-385
96. Reiss, Y., Goldstein, J. L., Seabra, M. C., Casey, P. J., and Brown, M. S. (1990) Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides Cell 62, 81-88
97. Bishop, W. R., Doll, R., and Kirschmeier, P. (2011) Farnesyl transferase inhibitors: From targeted cancer therapeutic to a potential treatment for progeria Enzymes 29, 275-303
98. Bos, J. L. (1989) Ras oncogenes in human cancer-a review Cancer Res. 49, 4682-4689
99. Lerner, E. C., Zhang, T. T., Knowles, D. B., Qian, Y. M., Hamilton, A. D., and Sebti, S. M. (1997) Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines Oncogene 15, 1283-1288
100. Raponi, M., Lancet, J. E., Fan, H., Dossey, L., Lee, G., Gojo, I., Feldman, E. J., Gotlib, J., Morris, L. E., Greenberg, P. L., Wright, J. J., Harousseau, J.-L., Loewenberg, B., Stone, R. M., De Porre, P., Wang, Y., and Karp, J. E. (2008) A 2-gene classifier for predicting response to the famesyltransferase inhibitor tipifarnib in acute myeloid leukemia Blood 111, 2589-2596
101. Abate-Pella, D., Zeliadt, N. A., Ochocki, J. D., Warmka, J. K., Dore, T. M., Blank, D. A., Wattenberg, E. V., and Distefano, M. D. (2012) Photochemical Modulation of Ras-Mediated Signal Transduction using Caged Farnesyltransferase Inhibitors: Activation via One- and Two-Photon Excitation ChemBioChem 13, 1009-1016
102. Yang, S. H., Bergo, M. O., Toth, J. I., Qiao, X., Hu, Y., Sandoval, S., Meta, M., Bendale, P., Gelb, M. H., Young, S. G., and Fong, L. G. (2005) Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation Proc. Natl. Acad. Sci. U. S. A. 102, 10291-10296
103. Fong, L. G., Frost, D., Meta, M., Qiao, X., Yang, S. H., Coffinier, C., and Young, S. G. (2006) A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria Science 311, 1621-1623
104. Gordon, L. B., Kleinman, M. E., Miller, D. T., Neuberg, D. S., Giobbie-Hurder, A., Gerhard-Herman, M., Smoot, L. B., Gordon, C. M., Cleveland, R., Snyder, B. D., Fligor, B., Bishop, W. R., Statkevich, P., Regen, A., Sonis, A., Riley, S., Ploski, C., Correia, A., Quinn, N., Ullrich, N. J., Nazarian, A., Liang, M. G., Huh, S. Y., Schwartzman, A., and Kieran, M. W. (2012) Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome Proc. Natl. Acad. Sci. U. S. A. 109, 16666-16671
105. Boston, C. s. H. (2009) Study of zoledronic acid, pravastatin and lonafarnib for patients with progeria; US National Institute of Health, http://clinicaltrials.gov/ct2/show/record/NCT00916747.
106. Kraus, J. M., Tatipaka, H. B., McGuffin, S. A., Chennamaneni, N. K., Karimi, M., Arif, J., Verlinde, C. L. M. J., Buckner, F. S., and Gelb, M. l. H. (2010) Second generation analogues of the cancer drug clinical candidate tipifarnib for anti-Chagas disease drug discovery J. Med. Chem. 53, 3887-3898
107. Carrico, D., Ohkanda, J., Kendrick, H., Yokoyama, K., Blaskovich, M. A., Bucher, C. J., Buckner, F. S., Van Voorhis, W. C., Chakrabarti, D., Croft, S. L., Gelb, M. H., Sebti, S. M., and Hamilton, A. D. (2004) In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability Bioorg. Med. Chem. 12, 6517-6526
108. Yokoyama, K., Trobridge, P., Buckner, F. S., Scholten, J., Stuart, K. D., Van Voorhis, W. C., and Gelb, M. H. (1998) The effects of protein farnesyltransferase inhibitors on trypanosomatids: inhibition of protein farnesylation and cell growth Mol. Biochem. Parasitol. 94, 87-97
109. Fletcher, S., Cummings, C. G., Rivas, K., Katt, W. P., Horney, C., Buckner, F. S., Chakrabarti, D., Sebti, S. M., Gelb, M. l. H., Van Voorhis, W. C., and Hamilton, A. D. (2008) Potent, plasmodium-selective farnesyltransferase inhibitors that arrest the growth of malaria parasites: Structure-activity relationships of ethylenediamine-analogue scaffolds and homology model validation J. Med. Chem. 51, 5176-5197
110. Walters, C. E., Pryce, G., Hankey, D. J. R., Sebti, S. M., Hamilton, A. D., Baker, D., Greenwood, J., and Adamson, P. (2002) Inhibition of Rho GTPases with protein prenyltransferase inhibitors prevents leukocyte recruitment to the central nervous system and attenuates clinical signs of disease in an animal model of multiple sclerosis J. Immunol. 168, 4087-4094
111. Coxon, F. P., Helfrich, M. H., Vant Hof, R., Sebti, S., Ralston, S. H., Hamilton, A., and Rogers, M. J. (2000) Protein geranylgeranylation is required for osteoclast formation, function, and survival: Inhibition by bisphosphonates and GGTI-298 J. Bone Mineral Res. 15, 1467-1476
112. Bordier, B. B., Marion, P. L., Ohashi, K., Kay, M. A., Greenberg, H. B., Casey, J. L., and Glenn, J. S. (2002) A prenylation inhibitor prevents production of infectious hepatitis delta virus particles J. Virol. 76, 10465-10472
113. Liu, Z., Meray, R. K., Grammatopoulos, T. N., Fredenburg, R. A., Cookson, M. R., Liu, Y., Logan, T., and Lansbury, P. T., Jr. (2009) Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinsons disease Proc. Natl. Acad. Sci. U. S. A. 106, 4635-4640
114. Duckworth, B. P., Xu, J., Taton, T. A., Guo, A., and Distefano, M. D. (2006) Site-specific, covalent attachment of proteins to a solid surface Bioconjugate Chem. 17, 967-974
115. Gauchet, C., Labadie, G. R., and Poulter, C. D. (2006) Regio- and chemoselective covalent immobilization of proteins through unnatural amino acids J. Am. Chem. Soc. 128, 9274-9275
116. Duckworth, B. P., Zhang, Z. Y., Hosokawa, A., and Distefano, M. D. (2007) Selective labeling of proteins by using protein farnesyltransferase ChemBioChem 8, 98-105
117. Xu, J., DeGraw, A. J., Duckworth, B. P., Lenevich, S., Tann, C.-M., Jenson, E. C., Gruber, S. J., Barany, G., and Distefano, M. D. (2006) Synthesis and reactivity of 6,7-dihydrogeranylazides: Reagents for primary azide incorporation into peptides and subsequent Staudinger ligation Chem. Biol. Drug Des. 68, 85-96
118. Tolstyka, Z. P., Richardson, W., Bat, E., Stevens, C. J., Parra, D. P., Dozier, J. K., Distefano, M. D., Dunn, B., and Maynard, H. D. (2013) Chemoselective Immobilization of Proteins by Microcontact Printing and Bio-orthogonal Click Reactions ChemBioChem 14, 2464-2471
119. Weinrich, D., Lin, P.-C., Jonkheijm, P., Nguyen, U. T. T., Schroeder, H., Niemeyer, C. M., Alexandrov, K., Goody, R., and Waldmann, H. (2010) Oriented Immobilization of Farnesylated Proteins by the Thiol-Ene Reaction Angew. Chem., Int. Ed. 49, 1252-1257
120. Choi, S.-r., Seo, J.-s., Bohaty, R. F. H., and Poulter, C. D. (2014) Regio- and chemoselective immobilization of proteins on gold surfaces Bioconjugate Chem. 25, 269-275
121. Seo, J.-s. and Poulter, C. D. (2014) Sandwich antibody arrays using recombinant antibody-binding Protein L Langmuir 30, 6629-6635
122. Dursina, B.-E., Reents, R., Niculae, A., Veligodsky, A., Breitling, R., Pyatkov, K., Waldmann, H., Goody, R. S., and Alexandrov, K. (2005) A genetically encodable microtag for chemo-enzymatic derivatization and purification of recombinant proteins Protein Expression Purif. 39, 71-81
123. Mahmoodi, M. M., Rashidian, M., Dozier, J. K., and Distefano, M. D. (2013) Chemoenzymatic site-specific reversible immobilization and labeling of proteins from crude cellular extract without prior purification using oxime and hydrazine ligation Curr. Protoc. Chem. Biol. 5, 89-109
124. Duckworth, B. P., Chen, Y., Wollack, J. W., Sham, Y., Mueller, J. D., Taton, T. A., and Distefano, M. D. (2007) A universal method for the preparation of covalent protein-DNA conjugates for use in creating protein nanostructures Angew. Chem., Int. Ed. 46, 8819-8822
125. Khatwani, S. L., Kang, J. S., Mullen, D. G., Hast, M. A., Beese, L. S., Distefano, M. D., and Taton, T. A. (2012) Covalent protein-oligonucleotide conjugates by copper-free click reaction Bioorg. Med. Chem. 20, 4532-4539
126. Yeo, J. E., Wickramaratne, S., Khatwani, S., Wang, Y.-C., Vervacke, J., Distefano, M. D., and Tretyakova, N. Y. (2014) Synthesis of Site-Specific DNA-Protein Conjugates and Their Effects on DNA Replication ACS Chem. Biol. 9, 1860-1868
127. Rashidian, M., Mahmoodi, M. M., Shah, R., Dozier, J. K., Wagner, C. R., and Distefano, M. D. (2013) A Highly Efficient Catalyst for Oxime Ligation and Hydrazone-Oxime Exchange Suitable for Bioconjugation Bioconjugate Chem. 24, 333-342
128. Rashidian, M., Kumarapperuma, S. C., Gabrielse, K., Fegan, A., Wagner, C. R., and Distefano, M. D. (2013) Simultaneous Dual Protein Labeling Using a Triorthogonal Reagent J. Am. Chem. Soc. 135, 16388-16396